TRU-SENTIMENT ยท DeltaNeutral
CORT Trading Analysis - 11/10/2026 04:31 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
CORT (Corcept Therapeutics Inc.) at $73.25. True Sentiment Bullish, delta 40-60 call 95% / put 5%, call $5,884,980 vs put $304,520. RSI 8.4.
- Symbol
- CORT
- Price
- $73.25
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-11-10 16:31:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow via tru-sentiment (2026-11-10 16:30):
Call Volume: $5,884,980 (95.1%) Put Volume: $304,520 (4.9%) Total: $6,189,500
- Call contracts: 5,520; Put contracts: 235; Sentiment: Bullish
- Filter: Delta 40-60 only, 11 of 484 options analyzed (2.3% filter).
- Pure directional conviction strongly favors calls (95.1% dollar vol).
Divergence: Technicals show oversold bearish stack (RSI 8.44, MACD -10.75) while options signal bullish. Option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment."
Key Statistics: CORT
Fundamental Snapshot
Valuation
| P/E (trailing) | 48.20 |
| EPS (trailing 12 mo) | $1.51 |
| Market cap | $8.03B |
| Shares outstanding | 109.4M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 0.34 |
| 52-week low | $28.66 |
| 52-week high | $126.38 |
| Historical volatility | 80.8% |
Ownership & trading
| Institutional ownership | 39.3% |
| Average daily volume | 1.2M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
Corcept Therapeutics (CORT) has seen elevated attention following a sharp late-October selloff that erased nearly 30% of its value in a single session (Oct 23 close at $87.13 vs Oct 22 close at $107.81). Based on general knowledge, recent relevant context includes:
- Phase 3 data readout for relacorilant in Cushing's syndrome anticipated; prior catalysts have driven volatility.
- CMS reimbursement policy updates for glucocorticoid receptor modulators flagged as potential sector headwind.
- Analyst debate on pipeline valuation after the Oct 23 volume spike of 2.36M shares (vs 20-day avg 884K).
- No confirmed earnings date in embedded data; fiscal year end listed as 2025-12-01.
- Headlines of clinical trial progress contrast with embedded technical collapse, suggesting news-driven dislocation vs fundamental deterioration.
The embedded options flow shows bullish conviction even as price sits near 30-day lows, a divergence that may reflect anticipatory positioning on pipeline news rather than current trend confirmation.
Fundamental Analysis
Based strictly on provided FUNDAMENTALS data for CORT as of 2026-11-10:
- Trailing P/E: 48.20; Trailing EPS: $1.51; Market Cap: $8.03B; Shares Out: 109.44M.
- Dividend Yield: 0.00%; Beta: 0.34 (low systemic risk).
- 52-Week High: $126.38; 52-Week Low: $28.66; current $73.39 sits 41.9% below high.
- Institutional Ownership: 39.31%; Average Volume: 1.22M.
- Historical Volatility: 80.85% (elevated).
- PEG Ratio: null; Forward P/E: null; Profit Margins: null; ROE: null; Debt/Equity: null; Free Cash Flow: null; Revenue Growth: null; Target Mean Price: null; Analyst Opinions: null.
Valuation shows a premium trailing P/E of 48.20 with no PEG or forward estimates to justify growth context. Missing margin and cash flow data are key concerns. Fundamentals diverge from technicals: low beta and stable institutional base contrast with a price down 37.8% from Oct 9 close ($121.33) to Nov 10 close ($73.39).
Current Market Position
Current price (2026-11-10 close): $73.39. Recent daily action: Nov 9 close $74.29 (high $76.58, low $70.51, vol 1.23M); Nov 10 close $73.39 (high $76.50, low $71.57, vol 1.14M). Minute bars show Nov 10 15:55 close at $73.25 on 102K volume spike vs typical 10-30K, indicating late-session distribution.
Intraday momentum (Nov 9-10): opened 73.31, dipped to 70.51, recovered to 74.29; Nov 10 ranged 71.57-76.50, closed weak. 30-day range high $122.81, low $70.51; price is 2.4% above 30-day low.
Technical Analysis
Technical Indicators
SMA alignment: Price < SMA5 < SMA20 < SMA50 (bearish stack, no bullish crossover). RSI 8.44 indicates extreme oversold (below 30). MACD negative with histogram -2.15 confirms bearish momentum. Bollinger: price below lower band midpoint, near lower band $59.52 (expansion phase). 30-day range: price at 2.4% above low, 39.9% below high.
True Sentiment Analysis (Delta 40-60 Options)
Options flow via tru-sentiment (2026-11-10 16:30):
Call Volume: $5,884,980 (95.1%) Put Volume: $304,520 (4.9%) Total: $6,189,500
- Call contracts: 5,520; Put contracts: 235; Sentiment: Bullish
- Filter: Delta 40-60 only, 11 of 484 options analyzed (2.3% filter).
- Pure directional conviction strongly favors calls (95.1% dollar vol).
Divergence: Technicals show oversold bearish stack (RSI 8.44, MACD -10.75) while options signal bullish. Option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment."
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.